ABEONA THERAPEUTICS INC. - Director's Dealing 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-09-20

Reporting Person: O'Malley Brendan M. (SVP, General Counsel)

Security	Shares	Ownership
Common stock	137454	Direct

Security	Exercise Price	Expiration	Underlying	Ownership
Stock Option (right to buy)	$1.15	2029-05-31	Common stock (55000)	Direct
Stock Option (right to buy)	$1.15	2030-03-16	Common stock (50000)	Direct
Stock Option (right to buy)	$2.34	2031-03-01	Common stock (100000)	Direct

F1: Includes 130,113 shares of unvested restricted stock, which will vest on various dates between September 30, 2021 and March 1, 2025.

F2: The options vest 25% on May 31, 2020, and in 36 equal monthly installments thereafter.

F3: The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter.

F4: The options vest 25% on March 1, 2022, and in 36 equal monthly installments thereafter.